Back

Association of left ventricular ejection fraction improvement with prognosis in patients with cardiac sarcoidosis: insights from the ILLUMINATE-CS study

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Cardiac amyloidosis, sarcoidosis, and inflammation Ventricular Remodelling ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Daichi Maeda

Juntendo University Graduate School of Medicine, Tokyo (Japan)

8 More presentations in this session

Presentation thumbnail
Delays in diagnosis and treatment initiation of ATTR cardiac amyloidosis: a real-world data analysis
Doctor J. Vogel (Essen, DE)
Abstract Slides Video
Presentation thumbnail
Transthyretin stabiliser therapy in patients with transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis
Mr V. Ribeiro (Teresina, BR)
Abstract Slides Video
Presentation thumbnail
Prevalence of transthyretin amyloid cardiomyopathy in patients hospitalised for heart failure with preserved ejection fraction in an LATAM center.
Mr S. Decotto (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Biomarkers for monitoring patients with cardiac amyloidosis during transthyretin-stabilizer therapy
Doctor J. Vogel (Essen, DE)
Abstract Slides
Presentation thumbnail
Relationship between changes in renal function after acute phase of tafamidis administration and left ventricular diastolic function at mid-term follow-up in transthyretin cardiac amyloidosis
Ms A. Senda (Kobe, JP)
Abstract Slides

Access the full session

Session thumbnail
Cardiac amyloidosis, sarcoidosis, and inflammation

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Prognostic impact of 18F-fluorodeoxyglucose positron emission tomography and 67gallium scintigraphy in cardiac sarcoidosis.
thumbnail
Congress Presentation
Health-related quality of life and prognosis in cardiac sarcoidosis
thumbnail
Congress Presentation
Multimodality imaging to improve detection and prognostication of right ventricular involvement in cardiac sarcoidosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources